| Authors: |
Baudin E; Department of Endocrine Oncology and Nuclear Medicine, Gustave Roussy Cancer Institute, Paris-Saclay University, Paris, France., Durand A; Department of Medical Oncology, Hospices Civils de Lyon, Hôpital Édouard Herriot, Université de Lyon, Lyon, France., Buikhuisen W; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Capdevila J; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain., Caplin M; Department of Gastroenterology, Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, UK., Deroose CM; Nuclear Medicine Unit, University Hospitals Leuven, Leuven, Belgium.; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Dromain C; Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Faggiano A; Endocrinology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Centre of Excellence, Sapienza University of Rome, Rome, Italy., Filosso PL; Department of Thoracic Surgery, San Giovanni Battista Hospital, University of Torino, Turin, Italy., Kaltsas G; Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece., Volante M; Department of Oncology, University of Turin at San Luigi Hospital, Orbassano, Torino, Italy., Walter T; Department of Medical Oncology, Hospices Civils de Lyon, Hôpital Édouard Herriot, Université de Lyon, Lyon, France., Garcia-Carbonero R; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Imas12 Research Institute, Medicine Faculty, Universidad Complutense de Madrid, Madrid, Spain. |